drugset / Trial / NCT02541955

Use of Acthar in Rheumatoid Arthritis (RA) Related Flares

NCT02541955

Phase 4 Completed 40 enrolled Veena Ranganath, MD, MS Mallinckrodt · collab
RandomizedParallel-groupOpen-labelDiagnostic

Summary

This is a Rheumatoid Arthritis (RA) study. The purpose of this research study is to determine in RA flare, whether musculoskeletal ultrasound (MSUS) inflammatory scores and/or disease activity scores improve with Acthar treatment.

Timeline

Start
2017-07-20
Primary completion
2025-05-06
Completion
2025-05-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acthar Peptide 40 iu
Comparator Acthar Peptide 80 iu

Indications